Tumours with CTCF haploinsufficiency can now be shown to exhibit four different hallmarks of cancer: sustained proliferative signalling, resisting cell death, evading growth suppressors and epigenetic disregulation of the genome.44 Our study provides further evidence of CTCF’s role as a haploinsufficient tumour suppressor gene. The gene discussed is CTCF; the disease is cancer.